SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹231 Cr | ₹154 Cr | ₹105 Cr | ₹79 Cr | ₹62 Cr |
What is the latest Profit & Loss Account Balance ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹231 Cr |
| Mar2025 | ₹154 Cr |
| Mar2024 | ₹105 Cr |
| Mar2023 | ₹79 Cr |
| Mar2022 | ₹62 Cr |
How is Profit & Loss Account Balance of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹231 Cr | 49.60 | |
| Mar2025 | ₹154 Cr | 47.23 | |
| Mar2024 | ₹105 Cr | 31.90 | |
| Mar2023 | ₹79 Cr | 27.77 | |
| Mar2022 | ₹62 Cr | - | |
Compare Profit & Loss Account Balance of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,112.2 Cr | -4.7% | 15.2% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -4.7% |
15.2% |
30.2% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses